<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
 <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 <link rel="stylesheet" type="text/css" href="savehtml.css"/>
 <title>Tgfbr2 --+&gt; Tgfbr1
 </title>
</head>
<body>
 <div class="props">
  <h1>ProtModification Tgfbr2 --+&gt; Tgfbr1</h1>
  <table>
   <tbody>
    <tr>
     <th align="left">Effect
     </th>
     <td>positive
     </td>
    </tr>
    <tr>
     <th align="left">Mechanism
     </th>
     <td>phosphorylation
     </td>
    </tr>
    <tr>
     <th align="left">Owner
     </th>
     <td>Public
     </td>
    </tr>
    <tr>
     <th align="left">URN
     </th>
     <td>urn:agi-ProtModification:inout-urn:agi-llid:7048:out-urn:agi-llid:7046::positive:phosphorylation
     </td>
    </tr>
    <tr>
     <th align="left">References
     </th>
     <td>13
     </td>
    </tr>
    <tr>
     <th align="left">Connectivity
     </th>
     <td>2
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9261125&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9261125:3
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In the presence of TGF-beta1, TbetaR-I/BMPR-IB and TbetaR-II/ActR-IIB formed heteromeric complexes with wild-type TbetaR-II and TbetaR-I, respectively, upon stable transfection in mink lung epithelial cell lines.
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>epithelia
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>lung
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12876289&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12876289:1026
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The constitutively active kinase domain of TbetaRII then activates TbetaRI by transphosphorylation of the GS box in the cytoplasmic domain ( 15 ).
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>J. Biol. Chem
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v278 i40 p38342 (2003)
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.jbc.org/cgi/content/full/278/40/38342" target="AGI_EXT_REF">http://www.jbc.org/cgi/content/full/278/40/38342
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>epithelia
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>prostate
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11936776&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11936776:7
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Because both TbetaR-I and TbetaR-II are required for signal transduction, the reduction of TbetaR-I levels on the alveolar epithelium may alter the sensitivity of AECs to the antiproliferative effects of TGF-beta1 present in increased quantities following bleomycin injury.
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>epithelia
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9681516&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9681516:1043
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>However, it is not known whether lactotropes express TbetaR-I and whether heteromeric interaction between TbetaR-I and TbetaR-II mediates ligand-dependent gene expression in these cells.
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Endocrinology
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v139 i8 p3620 (1998)
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://endo.endojournals.org/cgi/content/full/139/8/3620" target="AGI_EXT_REF">http://endo.endojournals.org/cgi/content/full/139/8/3620
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>pituitar
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=0&amp;dopt=AbstractPlus" target="AGI_EXT_REF">0:39038327
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9545258&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9545258:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Transforming growth factor beta (TGFbeta) signal transduction is mediated by two receptor Ser/Thr kinases acting in series, type II TGFbeta receptor (TbetaR-II) phosphorylating type I TGFbeta receptor (TbetaR-I).
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12015308&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12015308:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Endoglin cannot bind ligand on its own but requires the presence of the signaling receptors, supporting a critical role for the interaction between endoglin and TbetaRI or TbetaRII.
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9856985&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9856985:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Several studies have shown that TbetaR-II acts as a primary receptor, binding TGF-beta and phosphorylating TbetaR-I, whose kinase activity then propagates the signals.
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10026191&amp;dopt=AbstractPlus" target="AGI_EXT_REF">10026191:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Velocity centrifugation of endogenous receptors suggests that ligand-bound TbetaRI and TbetaRII form a heteromeric complex that is most likely a heterotetramer.
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9233797&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9233797:6
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>FKBP12 does not inhibit TbetaR-I association with TbetaR-II, but inhibits TbetaR-I phosphorylation by TbetaR-II.
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11212236&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11212236:1127
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Previously detected point mutations in TGFBR2 within the kinase domain have been shown to have functional effects that include defective autophosphorylation and hence inhibition of signal transduction, constitutive activation of trans -phosphorylation of TGFBR1 by TGFBR2 (4 , 17) , and generation of a dominant negative form (18) .
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Cancer Res
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v61 i2 p482 (2001)
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://cancerres.aacrjournals.org/cgi/content/full/61/2/482" target="AGI_EXT_REF">http://cancerres.aacrjournals.org/cgi/content/full/61/2/482
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12855402&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12855402:1330
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Gastr. Liver Phys
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v285 i5 pG1056 (2003)
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpgi.physiology.org/cgi/content/full/285/5/G1056" target="AGI_EXT_REF">http://ajpgi.physiology.org/cgi/content/full/285/5/G1056
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=14660579&amp;dopt=AbstractPlus" target="AGI_EXT_REF">14660579:1031
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>J. Biol. Chem
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v279 i8 p6840 (2004)
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.jbc.org/cgi/content/full/279/8/6840" target="AGI_EXT_REF">http://www.jbc.org/cgi/content/full/279/8/6840
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Source
     </th>
     <td>Ariadne Pathways
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
 </div>
</body>
</html>